Interestingly, a growing number of studies reported that AZIN1 expression increased in most cancer types [52], including gastric cancer [53], ovarian cancer [54] and prostate cancer [55] and colorectal cancer [56]. This evidence concerns the gene AZIN1 and prostate carcinoma.